Search

everythinglearnresearchcommunity

for

Search:↓

Many adult women suffer from persistent or late-onset acne, and while various treatments exist, finding the right one can be challenging.

Thyroid hormone may be useful for treating various skin conditions and needs more research.

A woman with a skin disorder was found to have hepatitis C, which may be linked, and was safely treated with methotrexate.

Use the least toxic, most specific treatments for skin diseases, considering side effects and individual patient needs.

Oral retinoids can cause side effects ranging from mild to severe, including birth defects, and require careful monitoring and contraception.

The most effective treatments for hair loss are minoxidil, finasteride, PRP, and hair transplants, with steroids and immunosuppressants for autoimmune types.

Oral spironolactone's effectiveness for adult female acne is not well-supported by strong evidence.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

The document concludes that proper diagnosis and treatment of follicular disorders are crucial, with specific treatments for conditions like acne, drug-induced eruptions, and rosacea.

New treatments for a chronic skin condition show promise, but individualized plans are crucial due to varying responses.

Vitamin A might be a safe extra treatment for dogs with sebaceous adenitis, but more research is needed to prove its effectiveness.

Stingless bee propolis may help regenerate hair follicles and improve pigment function in chemotherapy-induced hair loss.

Lichen planus is a skin condition that can resolve on its own, is linked to hepatitis C, and increases the risk of skin cancer.

Liposomes could improve how skin care products work but are costly and not very stable.

Some drugs can cause hair loss, change hair color and shape, or increase hair growth, and treatment may involve stopping the drug or using specific hair growth treatments.

Boosting Wnt signaling improves skin wound healing.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

The document concludes that there is no agreed-upon best method for measuring drug delivery within hair follicles and more research is needed to validate current techniques.

SLN suspensions work as well as commercial solutions for minoxidil delivery, but are non-corrosive, making them a promising alternative.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

Niosomes are a promising and effective way to deliver drugs through the skin.

Retinoids can prevent skin cancer in high-risk people but have side effects and require more research on dosing and effectiveness.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Hair loss from alopecia areata and androgenetic alopecia can be treated, but more effective and safer treatments are needed.

Researchers found a gene in hamsters that responds to male hormones and may be indirectly controlled by them.

Deformable vesicular carriers improve drug delivery for skin conditions and systemic treatments.

Understanding drug interactions, side effects, and patient-specific factors is crucial for effective dermatological care.

Researchers found a new mutation causing total hair loss from birth.

The document concludes that quick referral and appropriate treatments are crucial for managing common skin conditions and preventing permanent damage.

UVB is good for a skin condition in Asian kids, a lotion works for head lice, a drug helps with a skin blistering disorder, a foam reduces itchiness in skin inflammation, birthmarks can be more widespread, and criteria for a neurocutaneous disorder were agreed upon.